| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |